Ezrin, another member of the ezrin/radixin/moesin (ERM) family, is over-expressed in highly aggressive sarcomas [11], [12], as well as in breast cancer, being associated with higher metastasis rate [13]. This evidence concerns the gene EZR and breast carcinoma.